Sinergium Biotech: an innovative production model

Protein Sciences Zika Vaccine Shows Good Results in Preclinical Testing

Sinergium Biotech is an Argentine pharmaceutical company specialized in the research, development, production and marketing of vaccines and highly complex biotechnology products.

Protein Sciences Corporation, a leading vaccine development company and maker of Flublok Influenza Vaccine®, announced today that its lead protein based Zika vaccine candidate had good safety results and induced strong neutralizing antibodies against the Zika virus in preclinical studies.

September 11,  2016

January 23,  2017

ES

EN

Ruta Panamericana | Km 38.7 | Garín.
Province of Buenos Aires (P1619IEA). Argentina

Call center  (54 11) 3220-7300

 

Copyright 2016 : Sinergium Biotech

EN

ES

ES

EN

EN

ES